Cytokeratin 8/18 Antikörper
(Cytokeratin 8/18)
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Empfohlene Cytokeratin 8/18 Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
FACS, IHC (p), IHC, ICC
Validierungen
- (1)
Kat. Nr.
ABIN2597763
Menge
250 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
FACS, WB, IF, IHC, StM
Validierungen
- (1)
Kat. Nr.
ABIN6941377
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
FACS, WB, IF, IHC (p)
Validierungen
- (2)
Kat. Nr.
ABIN3024667
Menge
100 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren Cytokeratin 8/18 Produkten
: "An immunohistochemical prostate cell identification key indicates that aging shifts procollagen 1A1 production from myofibroblasts to fibroblasts in dogs prone to prostate-related urinary dysfunction." in: PLoS ONE, Vol. 15, Issue 7, pp. e0232564, (2020) (PubMed).: "Rheb1-Independent Activation of mTORC1 in Mammary Tumors Occurs through Activating Mutations in mTOR." in: Cell reports, Vol. 31, Issue 4, pp. 107571, (2020) (PubMed).
: "The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor." in: Disease models & mechanisms, Vol. 12, Issue 7, (2020) (PubMed).
: "A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials." in: Journal of mammary gland biology and neoplasia, Vol. 24, Issue 2, pp. 149-162, (2020) (PubMed).
: "Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program." in: Nature communications, Vol. 9, Issue 1, pp. 2547, (2018) (PubMed).
: "MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance. ..." in: Nature communications, Vol. 8, Issue 1, pp. 1728, (2018) (PubMed).
: "Integrin-mediated traction force enhances paxillin molecular associations and adhesion dynamics that increase the invasiveness of tumor cells into a three-dimensional extracellular matrix." in: Molecular biology of the cell, Vol. 28, Issue 11, pp. 1467-1488, (2017) (PubMed).
: "Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling." in: Oncogene, Vol. 35, Issue 35, pp. 4641-52, (2017) (PubMed).
: "The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα." in: Nature, Vol. 541, Issue 7638, pp. 541-545, (2017) (PubMed).
: "Prognostic relevance of epithelial-mesenchymal transition and proliferation in surgically treated primary parotid gland cancer." in: Journal of clinical pathology, (2016) (PubMed).
Haben Sie etwas anderes gesucht?
- Cytokeratin 79
- Cytokeratin 7
- Cytokeratin 5/18
- Cytokeratin 5
- Cytokeratin 28
- Cytokeratin 2
- Cytokeratin 19
- Cytokeratin 13
- Cytokeratin 1
- Cytohesin 4
- Cytohesin 3
- Cytohesin 2
- Cytohesin 1
- Cytochrome P450, Family 4, Subfamily A, Polypeptide 10
- Cytochrome P450, Family 3, Subfamily A, Polypeptide 13
- Cytochrome P450, Family 2, Subfamily J, Polypeptide 3
- Cytochrome P450, Family 2, Subfamily D, Polypeptide 7 Pseudogene 1
- Cytochrome P450, Family 2, Subfamily D, Polypeptide 4
- Cytochrome P450, Family 2, Subfamily D, Polypeptide 10
- Cytochrome P450, Family 2, Subfamily B, Polypeptide 1
Sie sind hier:
